Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK‑dependent manner

The treatment of advanced prostate cancer remains a formidable challenge due to the limited availability of effective treatment options. Therefore, it is imperative to identify promising druggable targets that provide substantial clinical benefits and to develop effective treatment strategies to ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Da Young, Lee, Sanghoon, Kim, Young Sik, Park, Soonbum, Bae, Sang-Mun, Cho, Eun A, Park, Eun-Jung, Park, Hyun Ho, Kim, Sang-Yeob, So, Insuk, Chun, Jung Nyeo, Jeon, Ju-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636720/
https://www.ncbi.nlm.nih.gov/pubmed/37888771
http://dx.doi.org/10.3892/or.2023.8655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636720/
https://www.ncbi.nlm.nih.gov/pubmed/37888771
http://dx.doi.org/10.3892/or.2023.8655

Ejemplares similares